{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:51Z","timestamp":1793967891663,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":244,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101136","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:15:05Z","timestamp":1789071305000},"page":"101136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Different patterns of activated partial thromboplastin time (APTT) clot waveforms predicting the presence of lupus anticoagulant"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4717-9207","authenticated-orcid":false,"given":"Kazutoshi","family":"Ebisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8604-3746","authenticated-orcid":false,"given":"Masaki","family":"Tanibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1516-7910","authenticated-orcid":false,"given":"Kunitoshi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5977-1489","authenticated-orcid":false,"given":"Takahiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinsp.2026.101136_bib0001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101136_bib0002","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12288-018-01072-8","article-title":"Utility of Lupus anticoagulant assays (APTT-LA, KCT, DPT and DRVVT) in detection of antiphospholipid syndrome (APS) in high-risk pregnancy cases","volume":"35","author":"Ahuja","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101136_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0040-1715838","article-title":"A novel assessment of factor VIII activity by template matching utilizing weighted average parameters from comprehensive clot waveform analysis","volume":"121","author":"Shimonishi","year":"2021","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0004","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/s41598-021-84776-8","article-title":"Clot waveform of APTT has abnormal patterns in subjects with COVID-19","volume":"11","author":"Shimura","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0005","article-title":"Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101136_bib0006","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11239-020-02318-x","article-title":"COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis","volume":"51","author":"Fan","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MBC.0000000000001265","article-title":"Clot waveform analysis in acute promyelocytic leukemia","volume":"35","author":"Terras","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101136_bib0008","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ijlh.13347","article-title":"Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype","volume":"43","author":"Milos","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/IJPM.IJPM_336_19","article-title":"Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A","volume":"64","author":"Dave","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101136_bib0010","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.14022","article-title":"Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab","volume":"16","author":"Nogami","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"19","key":"10.1016\/j.clinsp.2026.101136_bib0011","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.3390\/jcm12196320","article-title":"The evaluation of clot waveform analyses for assessing hypercoagulability in patients treated with factor VIII concentrate","volume":"12","author":"Matsumoto","year":"2023","journal-title":"J Clin Med"},{"issue":"20","key":"10.1016\/j.clinsp.2026.101136_bib0012","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.3390\/jcm11206142","article-title":"A clot waveform analysis of thrombin time using a small amount of thrombin is useful for evaluating the clotting activity of plasma independent of the presence of emicizumab","volume":"11","author":"Wada","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101136_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.258","article-title":"Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: a retrospective analysis","volume":"4","author":"Kanouchi","year":"2021","journal-title":"Health Sci Rep"},{"issue":"22","key":"10.1016\/j.clinsp.2026.101136_bib0014","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.3390\/jcm10225352","article-title":"A clot waveform analysis showing a hypercoagulable State in patients with malignant neoplasms","volume":"10","author":"Kobayashi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinsp.2026.101136_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231161591","article-title":"The detection of hypercoagulability in patients with acute cerebral infarction using a clot waveform analysis","volume":"29","author":"Kamon","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-60098-3","article-title":"Activated partial thromboplastin time-based clot waveform analysis: a potential for application in acute myocardial infarction and its complications","volume":"14","author":"Ng","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinsp.2026.101136_bib0017","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2021.03.030","article-title":"Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis","volume":"201","author":"Maeda","year":"2021","journal-title":"Thromb Res"},{"issue":"24","key":"10.1016\/j.clinsp.2026.101136_bib0018","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.3390\/jcm10245987","article-title":"Clot waveform analysis demonstrates low blood coagulation ability in patients with idiopathic thrombocytopenic purpura","volume":"10","author":"Wada","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinsp.2026.101136_bib0019","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11239-025-03128-9","article-title":"The role of activated partial thromboplastin time-clot waveform analysis in distinguishing positive samples of lupus anticoagulant from hemophilia A","volume":"58","author":"Parvathy","year":"2025","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101136_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.shj.2024.100357","article-title":"The risk for excessive anticoagulation with activated clotting time-guided monitoring in patients undergoing transcatheter aortic valve replacement","volume":"9","author":"Hokken","year":"2025","journal-title":"Struct Heart"},{"issue":"23","key":"10.1016\/j.clinsp.2026.101136_bib0021","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/01.CIR.0000077530.53367.E9","article-title":"Organization to assess Strategies for Ischemic Syndromes I. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.clinsp.2026.101136_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119887","article-title":"Comparison of clot waveform analysis with or without adjustment between prothrombin time and activated partial thromboplastin time assays to assess in vitro effects of direct oral anticoagulants","volume":"562","author":"Wakui","year":"2024","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0024","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","article-title":"A study of atypical APTT derivative curves on the ACL TOP coagulation analyser","volume":"33","author":"Solano","year":"2011","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101136_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-95389-w","article-title":"Effects of storage time and temperature on coagulation factor and natural anticoagulant activities in healthy individuals","volume":"15","author":"Nakanishi","year":"2025","journal-title":"Sci Rep"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:31:43Z","timestamp":1793964703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"alternative-id":["S1807593226002632"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101136","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different patterns of activated partial thromboplastin time (APTT) clot waveforms predicting the presence of lupus anticoagulant","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101136"}}